Clinic
Memorial Hermann Health System
Memorial Hermann Health System was paid $9.14M by Medicaid between Oct 2019 and Dec 2024, across 87 billing codes. Its largest line is 99284, emergency room visit (serious) — 59% of everything it billed.
33Billing provider infoMEMORIAL HERMANN HEALTH SYSTEM
SUGAR LAND, TX 77479
SUGAR LAND, TX 77479
33aNPI1295788735assigned 05/18/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$9.14M
24GClaims93,544
24DCodes billed87
24AFirst – last monthOct 2019 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#48 of 320
Median peer was paid$205K
This provider vs. median45×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 15 | $119.49 | |
| 2020 | 692 | $228K | |
| 2021 | 20,721 | $2.20M | |
| 2022 | 29,946 | $2.67M | |
| 2023 | 27,236 | $2.80M | |
| 2024incomplete | 14,934 | $1.23M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 59% | 12,354 | 11,683 | $5.41M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 13,631 | 13,275 | $1.64M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.4% | 1,812 | 1,654 | $493K |
| 80053 | Comprehensive metabolic panel | 3.8% | 8,066 | 7,174 | $350K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.3% | 11,149 | 9,655 | $211K |
| 81001 | 1.6% | 7,577 | 7,074 | $149K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.3% | 640 | 561 | $120K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 2,710 | 2,619 | $108K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.2% | 1,957 | 1,810 | $107K |
| 87400 | <1% | 2,505 | 1,267 | $79K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 196 | 173 | $41K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,824 | 1,689 | $35K |
75 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 239 | $31K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 153 | $30K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 911 | $29K |
| 84484 | <1% | 2,534 | $27K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,512 | $20K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 212 | $19K |
| 83690 | <1% | 1,354 | $18K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 278 | $16K |
| 84703 | <1% | 442 | $15K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 648 | $15K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 121 | $14K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,185 | $14K |
| 93975 | <1% | 73 | $14K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,525 | $13K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 450 | $11K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,105 | $10K |
| 87807 | <1% | 229 | $8K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 277 | $8K |
| 83880 | <1% | 762 | $7K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 155 | $7K |
| 84450 | <1% | 238 | $6K | |
| 84075 | <1% | 241 | $5K | |
| 76801 | <1% | 56 | $5K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 817 | $5K |
| 84702 | <1% | 277 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 460 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 703 | $4K |
| 82247 | <1% | 241 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 121 | $3K |
| 84155 | <1% | 238 | $3K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 42 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 48 | $2K |
| 85730 | <1% | 1,112 | $2K | |
| 82550 | <1% | 905 | $2K | |
| 85610 | <1% | 1,190 | $2K | |
| 87081 | <1% | 64 | $1K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 12 | $1K |
| 83735 | <1% | 808 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 282 | $1K |
| 82040 | <1% | 240 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 18 | $951.85 |
| J3490 | Unclassified drugs | <1% | 209 | $942.23 |
| 96376 | <1% | 127 | $925.01 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 52 | $889.00 |
| 80076 | <1% | 27 | $651.91 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 377 | $602.76 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 52 | $600.11 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 545 | $573.86 |
| 86900 | <1% | 201 | $329.77 | |
| 86901 | <1% | 188 | $308.05 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,409 | $302.38 |
| 83605 | <1% | 130 | $280.31 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 99 | $260.07 |
| 97162 | <1% | 12 | $235.98 | |
| 87040 | <1% | 57 | $199.97 | |
| 84145 | <1% | 32 | $180.91 | |
| 86850 | <1% | 12 | $180.42 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 16 | $128.45 |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 14 | $127.60 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 53 | $111.84 |
| 36000 | <1% | 14 | $108.15 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 549 | $102.45 |
| 84100 | <1% | 153 | $100.52 | |
| 81025 | <1% | 14 | $84.07 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 500 | $63.74 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 92 | $62.44 |
| 82947 | <1% | 180 | $53.68 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 71 | $43.90 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 37 | $31.56 |
| J2704 | Injection, propofol, 10 mg | <1% | 188 | $30.67 |
| G0378 | Hospital observation service, per hour | <1% | 27 | $21.81 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 15 | $14.11 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 350 | $10.56 |
| 80061 | Lipid panel | <1% | 13 | $5.99 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 30 | $3.31 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLARAWAY, DENNIS (CFO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.